Research use only. Read more

Healing & Repair

BPC-157

A synthetic pentadecapeptide derived from a gastric protein; researched for accelerating soft-tissue repair and modulating nitric oxide pathways.

Also known as: Body Protection Compound-157

Quick facts

Molecular weight

1,419 Da

Half-life

4 h

Frequency

daily

Admins / wk

7

Routes

SubQ / IM

Typical dose

250 mcg–500 mcg

Mechanism & positioning

A synthetic pentadecapeptide derived from a gastric protein; researched for accelerating soft-tissue repair and modulating nitric oxide pathways.

Researched for: tendon and ligament repair, gastric ulcer healing, angiogenesis.

Reconstitution defaults

Default vial

5 mg

BAC water

2 mL

Concentration

2500 mcg/mL

Doses per vial

~20

Other stocked vial sizes: 10 mg.

Calculate with this peptide

Documented pairwise interactions

  • caution

    BPC-157 + TB-500

    Frequently co-investigated for healing; no documented adverse pairwise interaction.

References

  • Sikiric P et al., Inflammopharmacology, 1993.
  • Chang CH et al., J Appl Physiol, 2011.

Related peptides in the Healing & Repair class

Frequently asked questions about BPC-157

What is the typical research dose range for BPC-157?
BPC-157 is most commonly investigated at 250 mcg–500 mcg per administration, daily. These values reflect documented research-stage protocols and are not medical recommendations.
What is the half-life of BPC-157?
BPC-157 has an approximate plasma half-life of 4 hours. Practical steady state is reached after roughly five half-lives — about 1 days under continuous administration.
How is BPC-157 administered in research protocols?
Published research uses subq or im administration. Typical reconstitution is 5 mg vial in 2 mL of bacteriostatic water, producing a concentration of 2500 mcg/mL.
What vial sizes are commonly available for BPC-157?
Common stocked vial sizes are 5 mg, 10 mg. The 5 mg vial is the most-used default in published protocols.